Yücel Çiğdem, Karatoprak Gökçe Şeker, Aktaş Yeşim
Department of Pharmaceutical Technology, Erciyes University, Faculty of Pharmacy, 38039 Kayseri, Turkey.
Department of Pharmacognosy, Erciyes University, Faculty of Pharmacy, 38039 Kayseri, Turkey.
J Nanosci Nanotechnol. 2018 Jun 1;18(6):3856-3864. doi: 10.1166/jnn.2018.15247.
Diabetes mellitus (DM) is a chronic metabolic disease and the subgroup of DM is called type II which is the most common form. The incidence of type II is increasing worldwide and it focuses on several new approaches to efficiently treatment of diabetes. Resveratrol (RSV) is known to be strong antioxidant and has an insulin-like effect in streptozotocin (STZ)-induced diabetic cells. It plays an active role at treatment of diabetes with reducing the oxidative stress, lowering glucose levels and protection of beta cells which are responsible for insulin secretion. In our study, we prepared two different RSV-loaded nanoliposomes (LPs), characterized in vitro and evaluated efficiencies of LPs on diabetes and related oxidative stress. Release and transport studies of RSV through dialyse membrane and pancreatic beta TC (β TC) cells were investigated from its solution and LPs. Stability studies were performed at two different conditions (4 °C and 25 °C ± 60% relative humidity) for 3 months. Particle size (PS), zeta potential (ZP), polydispersity index (PDI), encapsulation efficiency (EE) and type of the formulations were determined. β TC cell line was used in cell culture studies and cell viability was measured with using 3-(4,5-dimethyldiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT) cytotoxicity test. The antidiabetic effects of RSV LPs were investigated on β TC cell induced with glucose and STZ and we evaluated relationship between glucose and insulin concentration before and after incubation with LPs containing RSV. Antioxidant and preventive effects of RSV-loaded LPs against diabetes-associated oxidative stress were determined with superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) enzyme assay. When all results were evaluated together, these new developed liposomal formulations significantly decreased high glucose levels in diabetic cell groups synchronous with increasing insulin levels and they showed prolonged antioxidant activity against oxidative stress for 24 hours compared to RSV solution.
糖尿病(DM)是一种慢性代谢疾病,其亚组称为II型糖尿病,是最常见的形式。II型糖尿病在全球的发病率正在上升,并且聚焦于几种有效治疗糖尿病的新方法。白藜芦醇(RSV)是一种强效抗氧化剂,在链脲佐菌素(STZ)诱导的糖尿病细胞中具有胰岛素样作用。它在糖尿病治疗中发挥积极作用,可降低氧化应激、降低血糖水平并保护负责胰岛素分泌的β细胞。在我们的研究中,我们制备了两种不同的载有RSV的纳米脂质体(LPs),对其进行了体外表征,并评估了LPs对糖尿病及相关氧化应激的效果。研究了RSV从其溶液和LPs通过透析膜和胰腺βTC(βTC)细胞的释放和转运情况。在两种不同条件(4°C和25°C±60%相对湿度)下进行了3个月的稳定性研究。测定了粒径(PS)、zeta电位(ZP)、多分散指数(PDI)、包封率(EE)和制剂类型。在细胞培养研究中使用βTC细胞系,并使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)细胞毒性试验测量细胞活力。研究了RSV LPs对葡萄糖和STZ诱导的βTC细胞的抗糖尿病作用,并评估了与含RSV的LPs孵育前后葡萄糖和胰岛素浓度之间的关系。通过超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)酶测定确定了载有RSV的LPs对糖尿病相关氧化应激的抗氧化和预防作用。综合评估所有结果时,这些新开发的脂质体制剂与胰岛素水平升高同步显著降低了糖尿病细胞组中的高血糖水平,并且与RSV溶液相比,它们对氧化应激显示出长达24小时的延长抗氧化活性。